OCD Diagnosis and First-Line Treatment
Obsessive-compulsive disorder is diagnosed when a patient has intrusive, unwanted obsessions and/or compulsions that consume more than 1 hour daily or cause significant distress/impairment, and first-line treatment is either cognitive behavioral therapy with exposure and response prevention (ERP) or a selective serotonin reuptake inhibitor (SSRI) at high doses. 1
Diagnostic Criteria
The diagnosis requires meeting specific DSM-5 criteria that distinguish OCD from normal intrusive thoughts 1:
Core Features Required
Obsessions are defined by:
- Recurrent, persistent thoughts, urges, or impulses experienced as intrusive and unwanted
- Causing marked anxiety or distress
- The individual attempts to suppress or neutralize them with other thoughts or actions
Compulsions are defined by:
- Repetitive behaviors (hand washing, checking, ordering) or mental acts (counting, praying, repeating words)
- Performed in response to an obsession or according to rigid rules
- Aimed at preventing/reducing distress but not realistically connected to what they're designed to prevent, or clearly excessive
Critical Threshold Criteria
The symptoms must meet at least one of these:
- Time-consuming: >1 hour per day 1
- Cause clinically significant distress or impairment in social, occupational, or other functioning
Essential Exclusions
You must rule out 1:
- Substance effects (drugs, medications) or medical conditions causing symptoms
- Better explanation by another mental disorder (generalized anxiety disorder, body dysmorphic disorder, hoarding disorder, major depression, schizophrenia, autism spectrum disorder)
Insight Specifiers
Document the patient's level of insight 1:
- Good/fair insight: Recognizes OCD beliefs are probably not true
- Poor insight: Thinks OCD beliefs are probably true
- Absent insight/delusional: Completely convinced OCD beliefs are true
Additional Specifier
- Tic-related: Current or past history of tic disorder 1
Differential Diagnosis Pitfalls
Common mistakes to avoid 1:
- Generalized anxiety disorder/depression: Worries are about real-life concerns, less irrational, and lack compulsions
- Body dysmorphic disorder/hoarding/trichotillomania: Different focus of preoccupation and form of repetitive behaviors
- Substance use/paraphilias/impulse control disorders: Have ego-syntonic, gratifying components (at least initially)
- Schizophrenia: OCD with poor insight has OCD-related beliefs without additional psychotic features
- Normal intrusive thoughts: Only diagnose if time-consuming (>1 hour/day) AND causing substantial distress/impairment
Assessment Tools
Use validated instruments to confirm diagnosis and measure severity 1:
Structured diagnostic interviews:
- SCID-5 (Structured Clinical Interview for DSM-5) for adults
- ADIS-5 (Anxiety Disorders Interview Schedule) for adults and children
- MINI 7.0 (shorter option)
Severity measures:
- Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): Gold standard with symptom checklist and severity scale 1
- Children's Y-BOCS (CY-BOCS) for pediatric cases
- Florida Obsessive-Compulsive Inventory (FOCI): Shorter alternative
First-Line Treatment Algorithm
Both psychotherapy and pharmacotherapy are equally effective first-line options—choose based on patient preference, availability, and severity 1.
Option 1: Cognitive Behavioral Therapy with Exposure and Response Prevention
ERP is the most effective psychotherapy with high effect sizes 1, 2:
- Dose: 10-20 sessions initially 1
- Format options: In-person, internet-based, group, or individual 1
- Maintenance: Monthly booster sessions for 3-6 months after response 1
Key principle: Patients systematically confront feared situations while preventing compulsive responses, leading to habituation and extinction of anxiety.
Option 2: Selective Serotonin Reuptake Inhibitors
SSRIs are first-line pharmacotherapy based on efficacy, tolerability, and safety 1:
Critical dosing principles:
- Use higher doses than for depression or other anxiety disorders 1
- Maximum recommended or tolerated dose required 1
- Duration: Minimum 8-12 weeks to assess efficacy 1
- Maintenance: 12-24 months minimum after achieving remission 1
SSRI selection: All SSRIs have similar effect sizes—choose based on 1:
- Adverse effect profile (initial GI symptoms, sexual dysfunction common)
- Drug interactions
- Past treatment response
- Comorbid medical conditions
- Cost and availability
Clomipramine (tricyclic SRI) is equally effective but has lower tolerability than SSRIs, making it second-line 1.
Combination Therapy
If monotherapy inadequate, combine CBT with SSRI 1:
- Larger effect sizes than SSRI augmentation with antipsychotics 1
- Consider when CBT alone or SSRI alone insufficient
Treatment-Resistant OCD Strategies
Approximately 50% fail to fully respond to first-line treatment 1. For inadequate response:
Second-line options 1:
- Switch to different SSRI
- Switch to clomipramine
- Switch to SNRI (serotonin-noradrenaline reuptake inhibitor)
- Augment SSRI with atypical antipsychotic (low dose)
- Augment SSRI with clomipramine
Evidence note: Fluoxetine plus clomipramine was superior to fluoxetine plus quetiapine in treatment-resistant OCD 1.
Special Considerations
Pediatric acute-onset cases: Consider PANDAS (pediatric autoimmune neuropsychiatric disorders associated with Streptococcus) or broader paediatric acute-onset neuropsychiatric syndrome if sudden onset following infection 1.
Comorbidities: Present in 70-90% of cases—screen for depression, anxiety disorders, tic disorders 2. Adjust treatment algorithm accordingly (e.g., mood stabilizers if bipolar disorder present) 1.
Suicidal ideation: Monitor closely, especially with comorbidities 3.